PRESS RELEASE: FDA Authorizes Injection of Tumor Targeted Gene Therapy Directly into Cerebrospinal Fluid for Leptomeningeal Disease

DNG64-CAR-V (DeltaRex-G), A Novel Off-The-Shelf Intraventricular Gene Therapy for Brain Tumors, Leukemia, Lymphoma and Cancers That Have Spread to the Brain